Wu J Y, Lei K Y
Department of Nutritional Sciences, University of Arizona, Tucson 85721, USA.
Proc Soc Exp Biol Med. 1996 Sep;212(4):369-77. doi: 10.3181/00379727-212-44028.
This study was designed to determine whether an enhanced intestinal synthesis of apolipoprotein (apo) A-I is associated with the hyperapolipoproteinemia observed in copper-deficient rats. Male weanling Sprague-Dawley rats were assigned to two dietary treatments, Cu deficient (0.6 ppm Cu) and Cu adequate (6.0 ppm Cu) for 6 weeks. In vivo studies were then performed after rats were injected with a flooding dose of 150 microM [3H]phenylalanine (PHE, 50 microCi/ml/100 g body wt). Three rats from each treatment were sacrificed at 5, 10, 15, 30, and 60 min postinjection. The small intestine was rapidly rinsed and frozen in liquid N2. In vitro studies were performed by labeling freshly isolated 6-cm segments from duodenum, jejunum and ileum with [3H]PHE (33 microCi/ml, 49.7 Cl/mmol) in PHE-free minimum essential medium for 7 and 14 min. In vivo and in vitro intestinal samples were sonicated, solubilized in 1% Triton X-100, and centrifuged to provide the detergent soluble fraction for the isolation of nascent apo A-I and total protein. Radioactivities associated with nascent apo A-I isolated by immunoprecipitation and SDS-PAGE, and with total protein precipitated by trichloroacetic acid, were measured to determine the influence of Cu deficiency on nascent apo A-I and total protein synthesis. In the Cu-deficient small intestine, the synthesis of total protein was measured only in the duodenum and was enhanced after 1 hr for the in vivo studies. Moreover, total protein synthesis was enhanced at both 7 and 14 min of the in vitro studies for all three small intestinal segments of the Cu-deficient rats. Apo A-I synthesis was measured only at the jejunum and was also enhanced by Cu deficiency in the in vitro studies. Thus, an increase in intestinal apo A-I synthesis may contribute to the elevated plasma apo A-I level in Cu-deficient rats.
本研究旨在确定载脂蛋白(apo)A-I肠道合成增强是否与缺铜大鼠中观察到的高载脂蛋白血症相关。将雄性断乳斯普拉格-道利大鼠分为两种饮食处理组,即缺铜(0.6 ppm铜)组和铜充足(6.0 ppm铜)组,为期6周。在大鼠注射150 microM [3H]苯丙氨酸(PHE,50 microCi/ml/100 g体重)的冲击剂量后,进行体内研究。每种处理组的3只大鼠在注射后5、10、15、30和60分钟处死。迅速冲洗小肠并在液氮中冷冻。通过在无PHE的最低必需培养基中用[3H]PHE(33 microCi/ml,49.7 Cl/mmol)标记新鲜分离的十二指肠、空肠和回肠的6厘米节段7分钟和14分钟,进行体外研究。对体内和体外肠道样本进行超声处理,溶解于1% Triton X-100中,离心以提供去污剂可溶部分,用于分离新生apo A-I和总蛋白。测量通过免疫沉淀和SDS-PAGE分离的新生apo A-I以及通过三氯乙酸沉淀的总蛋白的放射性,以确定铜缺乏对新生apo A-I和总蛋白合成的影响。在缺铜的小肠中,仅在十二指肠测量总蛋白合成,体内研究在1小时后增强。此外,缺铜大鼠所有三个小肠节段在体外研究的7分钟和14分钟时总蛋白合成均增强。仅在空肠测量apo A-I合成,体外研究中铜缺乏也使其增强。因此,肠道apo A-I合成增加可能导致缺铜大鼠血浆apo A-I水平升高。